Children receiving biologic agents require regular monitoring to assess the efficacy of the treatment and to detect any adverse effects early. This often includes regular blood tests to check for infection markers, liver function, and other relevant parameters. Clinical assessments to monitor disease activity and growth parameters are also crucial.
